Bone marrow transplantation · 2000
Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma.
Клинический случайСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cabrera R, Díaz-Espada F, Barrios Y, Briz M, Forés R, Barbolla L, Sanjuán I, Regidor C, Peñalver F J, Fernández M N
Аннотация
A 48-year-old patient with IgA k multiple myeloma received a BMT from his HLA-matched sibling. After transplantation, the disease relapsed. Melphalan therapy followed by reinfusion of haemopoietic blood stem cells collected from the patient led to the improvement of the clinical status, although mixed chimerism and an elevated serum IgA persisted. Successful donor immunisation against an immunogenic preparation of the recipient monoclonal protein was performed before the infusion of donor T lymphocytes (DLI) into the patient. Ten weeks after the lymphocyte infusions, no monoclonal band was evidenced and donor complete chimerism was detected. The patient did not develop GVHD. Once complete remission was achieved, the idiotype vaccine was administered to the patient. Nineteen months after DLI, the patient remains in remission. Bone Marrow Transplantation (2000).
Предметные рубрики MeSH
Antineoplastic Agents, AlkylatingAntineoplastic Combined Chemotherapy ProtocolsBlood DonorsBone Marrow TransplantationChimeraCombined Modality TherapyDexamethasoneDoxorubicinGraft SurvivalHumansImmunizationImmunoglobulin AImmunoglobulin IdiotypesImmunoglobulin kappa-ChainsImmunotherapy, AdoptiveLymphocyte TransfusionMaleMelphalanMiddle AgedMultiple MyelomaMyeloma ProteinsRemission InductionSalvage TherapyT-LymphocytesVincristine